title: Contribution of host-derived tissue factor to tumor neovascularization.
abstract: OBJECTIVE
  The role of host-derived tissue factor (TF) in tumor growth, angiogenesis, and metastasis has hitherto been unclear and was investigated in this study.
  
  
  RESULTS
  We compared tumor growth, vascularity, and responses to cyclophosphamide (CTX) of tumors in wild-type (wt) mice, or in animals with TF levels reduced by 99% (low-TF mice). Global growth rate of 3 different types of transplantable tumors (LLC, B16F1, and ES teratoma) or metastasis were unchanged in low-TF mice. However, several unexpected tumor/context-specific alterations were observed in these mice, including: (1) reduced tumor blood vessel size in B16F1 tumors; (2) larger spleen size and greater tolerance to CTX toxicity in the LLC model; (3) aborted tumor growth after inoculation of TF-deficient tumor cells (ES TF(-/-)) in low-TF mice. TF-deficient tumor cells grew readily in mice with normal TF levels and attracted exclusively host-related blood vessels (without vasculogenic mimicry). We postulate that this complementarity may result from tumor-vascular transfer of TF-containing microvesicles, as we observed such transfer using human cancer cells (A431) and mouse endothelial cells, both in vitro and in vivo.
  
  
  CONCLUSIONS
  Our study points to an important but context-dependent role of host TF in tumor formation, angiogenesis and therapy.
authors.affiliation: Henderson Research Centre, McMaster University, Hamilton, ON, Canada.
authors.forename: Joanne
authors.initials: J
authors.lastname: Yu
authors.forename: Linda
authors.initials: L
authors.lastname: May
authors.forename: Chloe
authors.initials: C
authors.lastname: Milsom
authors.forename: G Mark
authors.initials: GM
authors.lastname: Anderson
authors.forename: Jeffrey I
authors.initials: JI
authors.lastname: Weitz
authors.forename: James P
authors.initials: JP
authors.lastname: Luyendyk
authors.forename: George
authors.initials: G
authors.lastname: Broze
authors.forename: Nigel
authors.initials: N
authors.lastname: Mackman
authors.forename: Janusz
authors.initials: J
authors.lastname: Rak
mesh_terms: D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000494:pharmacology; D018827:Carcinoma, Lewis Lung / Q000098:blood supply* / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D045744:Cell Line, Tumor; D002470:Cell Survival; D003520:Cyclophosphamide / Q000494:pharmacology; D053595:Embryonic Stem Cells / Q000378:metabolism; D042783:Endothelial Cells / Q000378:metabolism; D006801:Humans; D008546:Melanoma, Experimental / Q000098:blood supply* / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D016513:Mice, SCID; D009362:Neoplasm Metastasis; D014411:Neoplastic Stem Cells / Q000378:metabolism; D009389:Neovascularization, Pathologic / Q000378:metabolism*; D022142:Secretory Vesicles / Q000378:metabolism; D013724:Teratoma / Q000098:blood supply* / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D013925:Thromboplastin / Q000172:deficiency / Q000378:metabolism*; D013997:Time Factors
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003520:Cyclophosphamide; D013925:Thromboplastin
references.citation: J Clin Invest. 1998 Feb 1;101(3):560-9
references.pmid: 9449688
references.citation: Cancer Res. 2005 Oct 1;65(19):8878-86
references.pmid: 16204059
references.citation: Int J Cancer. 2007 Mar 15;120(6):1261-7
references.pmid: 17192924
references.citation: Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1500-5
references.pmid: 12231573
references.citation: Blood. 2005 Feb 15;105(4):1734-41
references.pmid: 15494427
references.citation: J Thromb Haemost. 2004 Nov;2(11):2065-7
references.pmid: 15550054
references.citation: Chest. 2003 Sep;124(3 Suppl):58S-68S
references.pmid: 12970125
references.citation: Thromb Res. 2008;122(3):418-26
references.pmid: 18206217
references.citation: Cancer Res. 1992 Dec 15;52(24):6969-75
references.pmid: 1360873
references.citation: Curr Med Chem. 2004 Sep;11(17):2275-90
references.pmid: 15379712
references.citation: Cancer Res. 2005 Jun 15;65(12):5365-73
references.pmid: 15958585
references.citation: Nat Med. 2004 May;10(5):502-9
references.pmid: 15098027
references.citation: Blood. 2007 Jul 1;110(1):133-41
references.pmid: 17371949
references.citation: Int J Cancer. 1991 Feb 1;47(3):466-72
references.pmid: 1993557
references.citation: Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8663-8
references.pmid: 10411932
references.citation: J Thromb Haemost. 2005 Aug;3(8):1800-14
references.pmid: 16102047
references.citation: Nat Rev Cancer. 2003 Jun;3(6):411-21
references.pmid: 12778131
references.citation: EMBO J. 2003 Aug 15;22(16):4091-102
references.pmid: 12912908
references.citation: Am J Pathol. 2007 Oct;171(4):1342-51
references.pmid: 17823292
references.citation: Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6922-6
references.pmid: 9192667
references.citation: Am J Pathol. 2001 Apr;158(4):1325-34
references.pmid: 11290550
references.citation: Blood. 2005 Sep 1;106(5):1604-11
references.pmid: 15741221
references.citation: Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1687-93
references.pmid: 17556654
references.citation: Blood. 2008 Jan 1;111(1):190-9
references.pmid: 17901245
references.citation: Nat Rev Cancer. 2007 Jun;7(6):475-85
references.pmid: 17522716
references.citation: Cancer Res. 2003 Jun 1;63(11):2997-3000
references.pmid: 12782609
references.citation: Nat Med. 1996 Feb;2(2):209-15
references.pmid: 8574967
references.citation: Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2311-5
references.pmid: 10051638
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12917-22
references.pmid: 14561896
references.citation: J Thromb Haemost. 2007 Aug;5(8):1584-7
references.pmid: 17663729
references.citation: Pathophysiol Haemost Thromb. 2006;35(1-2):103-10
references.pmid: 16855354
references.citation: J Clin Invest. 1994 Sep;94(3):1320-7
references.pmid: 7521887
references.citation: J Thromb Haemost. 2007 Dec;5(12):2550-2
references.pmid: 17883595
references.citation: Lab Invest. 2001 Dec;81(12):1669-81
references.pmid: 11742037
references.citation: N Engl J Med. 1988 Feb 18;318(7):404-7
references.pmid: 3340118